SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations of federal and state laws by certain officers of the companies of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), UnitedHealth Group Incorporated (NYSE: UNH), Blue Ridge Bankshares, Inc. (NYSE: BRBS), and Amplitude, Inc. (NASDAQ: AMPL). Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) Johnson Fistel, LLP is investigating potential claims on behalf of Aldeyra Therapeutics, Inc. against certain of its officers and directors. If you are a current, long-termshareholder of Aldeyra holding shares before March 17, 2022, you may have standing to hold Aldeyra harmless from the alleged harm caused by the Company's officers and directors by making them personally responsible. You may also be able to assist in reforming the Company's corporate governance to prevent future wrongdoing. You can click or copy and paste the link below in a browser to join this action: https://www.cognitoforms.com/JohnsonFistel/AldeyraTherapeuticsInc Recently a class action lawsuit was filed against the company. The lawsuit alleges Aldeyra made materially false and/or misleading statements and/or failed to disclose material adverse facts about the Company’s business, operations, and compliance policies, including: (i) the ADX-2191 new drug application (“NDA”) did not include adequate and well-controlled investigations and thus failed to show substantial evidence of ADX-2191’s effectiveness; (ii) as a result, the FDA was unlikely to approve the ADX-2191 NDA in its current form; and (iii) accordingly, the Company had overstated ADX-2191’s clinical and/or commercial prospects. UnitedHealth Group Incorporated (NYSE: UNH) Johnson Fistel, LLP is investigating potential claims on behalf of UnitedHealth Group Incorporated against certain of its officers and directors. If you are a current, long-term shareholder of UnitedHealth Group Incorporated, continuously holding your shares, you may have standing to hold the company harmless from the alleged harm caused by the Company's officers and directors by making them personally responsible. You may also be able to assist in reforming the Company's corporate governance to prevent future wrongdoing. You can click or copy and paste the link below in a browser to join this action: https://www.cognitoforms.com/JohnsonFistel/UnitedHealthGroupIncorporated Blue Ridge Bankshares, Inc. (NYSE: BRBS) Johnson Fistel, LLP is investigating potential claims on behalf of Blue Ridge Bankshares, Inc. against certain of its officers and directors. If you are a current, long-term shareholder of Blue Ridge Bankshares holding shares before March 10, 2023, you can click or copy and paste the link below in a browser to join this action: https://www.cognitoforms.com/JohnsonFistel/BlueRidgeBanksharesInc Recently a class action lawsuit was filed against Blue Ridge Bankshares. According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Blue Ridge Bankshares, Inc.’s financial statements from March 10, 2023 to the present included certain errors; (2) as a result, Blue Ridge Bankshares would need to restate its previously filed financial statements from March 10, 2023 to October 31, 2023; and (3) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times. When the true details entered the market, the lawsuit claims that investors suffered damages. Amplitude, Inc. (NASDAQ: AMPL) Johnson Fistel, LLP is investigating potential claims on behalf of Amplitude, Inc. against certain of its officers and directors. If you are a current, long-term shareholder of Amplitude holding shares before September 21, 2021, you can click or copy and paste the link below in a browser to join this action: https://www.cognitoforms.com/JohnsonFistel/AmplitudeInc Recently a class action lawsuit was filed against Amplitude. The class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) Amplitude’s land-and-expand strategy was years away from significantly accelerating revenues among its newer client cohorts; and (ii) the rapid acceleration in Amplitude’s second quarter of 2021 results resulted from the ephemeral effects of the COVID-19 pandemic which had not continued by the start of the Class Period, as Amplitude clients were expanding at a slower pace. About Johnson Fistel, LLP: Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. Johnson Fistel seeks to recover losses incurred due to violations of federal securities laws. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes. Attorney advertising. Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices. Johnson Fistel, LLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content. Contact: Johnson Fistel, LLP 501 W. Broadway, Suite 800, San Diego, CA 92101 James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471 [email protected] or [email protected]
Aldeyra, UnitedHealth Group Incorporated, Blue Ridge Bankshares, and Amplitude Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...